3‐(4‐Methyl­phenoxy­meth­yl)‐4‐phenyl‐1H‐1,2,4‐triazole‐5(4H)‐thione

By  

Acta Crystallographica Section E, Vol. 62, Iss. 7, 2006-07 ,pp. : o2890-o2892

John Wiley & Sons Inc

Access to resources Recommend Favorite

3′‐Methyl‐2‐[5‐(4‐methyl­phenoxy­meth­yl)‐4‐phenyl‐4H‐1,2,4‐triazol‐5‐ylsulfan­yl]acetanilide

By  

Acta Crystallographica Section E, Vol. 62, Iss. 12, 2006-12 ,pp. : o5820-o5822

John Wiley & Sons Inc

Access to resources Recommend Favorite

3‐[(5‐Methyl‐2‐oxo‐1,3‐benzoxazol‐3‐yl)methyl]‐4‐phenyl‐1H‐1,2,4‐triazole‐5(4H)‐thione

By  

Acta Crystallographica Section E, Vol. 63, Iss. 5, 2007-05 ,pp. : o2463-o2463

John Wiley & Sons Inc

Access to resources Recommend Favorite

4‐Phenyl‐3‐[(1H‐1,2,4‐triazol‐1‐yl)­methyl]‐1H‐1,2,4‐triazole‐5‐thione

By  

Acta Crystallographica Section E, Vol. 61, Iss. 2, 2005-02 ,pp. : o393-o395

John Wiley & Sons Inc

Access to resources Recommend Favorite

4‐Amino‐5‐(4‐chloro­phenoxy­meth­yl)‐2‐(2‐cyano­ethyl)‐2H‐1,2,4‐triazole‐3(4H)‐thione monohydrate

By  

Acta Crystallographica Section E, Vol. 62, Iss. 5, 2006-05 ,pp. : o1928-o1929

John Wiley & Sons Inc

Access to resources Recommend Favorite